Iminosugars: promising therapeutics for influenza infection
Influenza virus causes three to five million severe respiratory infections per year in seasonal epidemics, and sporadic pandemics, three of which occurred in the 20th century and are a continuing global threat. Currently licensed antivirals exclusively target the viral neuraminidase or M2 ion channe...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Taylor and Francis
2016
|